MedPath

Cytacoat AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Early Phase 1
1 (33.3%)

Evaluation of Safety and Performance of the CytaCoat Lubricious Infection Prevention (LIP) Foley Catheter

Early Phase 1
Completed
Conditions
Safety of the CytaCoat LIP Foley Catheter
Tolerability of the CytaCoat LIP Foley Catheter
First Posted Date
2024-02-05
Last Posted Date
2024-11-07
Lead Sponsor
CytaCoat AB
Target Recruit Count
30
Registration Number
NCT06242600
Locations
🇸🇪

Sahlgrenska University Hospital, Gothenburg, Sweden

A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization

Not Applicable
Completed
Conditions
Nosocomial Infections
Pneumonia, Ventilator-Associated
First Posted Date
2016-04-29
Last Posted Date
2017-02-01
Lead Sponsor
CytaCoat AB
Target Recruit Count
48
Registration Number
NCT02756351
Locations
🇸🇪

Neonatal, Karolinska University Hospital, Stockholm, Stockholm County, Sweden

News

No news found
© Copyright 2025. All Rights Reserved by MedPath